Humana Inc. (HUM) Debt to Equity Ratio: 0.73
Is Humana Inc.’s debt to equity ratio high or low?
Humana Inc.'s debt to equity ratio of 0.73 is in line with its 5-year average of 0.72, near the high end of its 5-year range (0.52–0.82).
The debt to equity ratio for Humana Inc. (HUM) is 0.73 as of Wednesday, June 10, 2026. It is below its 12-month average by 1.35% (0.74).
HUM Debt to Equity Ratio Chart
HUM Average Debt to Equity Ratio Chart
HUM Current vs Average Debt to Equity Ratio Chart
HUM Debt to Equity Ratio Metrics
DEBT TO EQUITY RATIO
0.73
DEBT TO EQUITY RATIO AVG TTM
0.74
DEBT TO EQUITY RATIO AVG 3Y
0.75
DEBT TO EQUITY RATIO AVG 5Y
0.72
DEBT TO EQUITY RATIO AVG 10Y
0.61
DEBT TO EQUITY RATIO AVG 15Y
0.51
DEBT TO EQUITY RATIO AVG 20Y
0.48
CURRENT VS TTM AVG
-1.35%
CURRENT VS 3Y AVG
-2.67%
CURRENT VS 5Y AVG
+0.92%
CURRENT VS 10Y AVG
+19.32%
CURRENT VS 15Y AVG
+43.14%
CURRENT VS 20Y AVG
+52.54%
HUM Competitors' Debt to Equity Ratio
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humana Inc. (HUM) | $43.78B | 0.73 | 0.74 | 0.75 | 0.72 |
| IDEXX Laboratories, Inc. (IDXX) | $44.47B | 0.67 | 0.65 | 1.10 | 1.25 |
| Agilent Technologies, Inc. (A) | $37.17B | 0.50 | 0.55 | 0.53 | 0.52 |
| Zoetis Inc. (ZTS) | $34.20B | 2.85 | 2.13 | 1.86 | 1.81 |
| Centene Corporation (CNC) | $31.94B | 0.94 | 0.84 | 0.83 | 0.81 |
| Medline Inc. (MDLN) | $30.90B | 1.17 | 1.09 | 0.79 | 0.79 |
| IQVIA Holdings Inc. (IQV) | $30.60B | 2.49 | 2.41 | 2.34 | 2.26 |
| DexCom, Inc. (DXCM) | $29.24B | 0.51 | 0.87 | 1.00 | 1.01 |
| Biogen Inc. (BIIB) | $29.00B | 0.38 | 0.39 | 0.44 | 0.53 |
| Veeva Systems Inc. (VEEV) | $26.73B | 0.01 | 0.01 | 0.01 | 0.02 |
Financial Health
Debt/Equity
0.73
Current Ratio
0.72
Humana Inc. Debt to Equity Ratio Formula & Definition
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Humana Inc. Debt to Equity Ratio FAQ
- What is the debt to equity ratio for Humana Inc. (HUM)?
- The debt to equity ratio for HUM stock is 0.73.
- Is Humana Inc.'s debt to equity ratio high or low?
- Humana Inc.'s debt to equity ratio of 0.73 is in line with its 5-year average of 0.72, near the high end of its 5-year range (0.52–0.82).
- What is the TTM average debt to equity ratio for Humana Inc. (HUM)?
- The TTM average debt to equity ratio for HUM stock is 0.74.
- What is the 3Y average debt to equity ratio for Humana Inc. (HUM)?
- The 3Y average debt to equity ratio for HUM stock is 0.75.
- What is the 5Y average debt to equity ratio for Humana Inc. (HUM)?
- The 5Y average debt to equity ratio for HUM stock is 0.72.
- What is the 10Y average debt to equity ratio for Humana Inc. (HUM)?
- The 10Y average debt to equity ratio for HUM stock is 0.61.
- What is the 15Y average debt to equity ratio for Humana Inc. (HUM)?
- The 15Y average debt to equity ratio for HUM stock is 0.51.
- What is the 20Y average debt to equity ratio for Humana Inc. (HUM)?
- The 20Y average debt to equity ratio for HUM stock is 0.48.
Humana Inc. Debt to Equity Ratio History
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2025-12-31 | 0.73 |
| 2024-12-31 | 0.75 |
| 2023-12-31 | 0.75 |
| 2022-12-31 | 0.77 |
| 2021-12-31 | 0.82 |
| 2020-12-31 | 0.52 |
| 2019-12-31 | 0.51 |
| 2018-12-31 | 0.60 |
| 2017-12-31 | 0.50 |
| 2016-12-31 | 0.38 |
| 2015-12-31 | 0.40 |
| 2014-12-31 | 0.40 |
| 2013-12-31 | 0.28 |
| 2012-12-31 | 0.30 |
| 2011-12-31 | 0.21 |
| 2010-12-31 | 0.24 |
| 2009-12-31 | 0.29 |
| 2008-12-31 | 0.43 |
| 2007-12-31 | 0.42 |
| 2006-12-31 | 0.42 |
| 2005-12-31 | 0.33 |
| 2004-12-31 | 0.40 |
| 2003-12-31 | 0.47 |
| 2002-12-31 | 0.44 |
| 2001-12-31 | 0.48 |
| 2000-12-31 | 0.44 |
| 1999-12-31 | 0.97 |
| 1998-12-31 | 0.89 |
| 1997-12-31 | 0.99 |
| 1996-12-31 | 0.17 |
Related Metrics
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- James A. Rechtin